Vitamin C improves the effect of a new nitric oxide donor on the vascular smooth muscle from renal hypertensive rats

Nitric Oxide - Biology and Chemistry

Volumn 18, Issue 3, 2008, Pages 176-183

  Rodrigues, G J ^a   Lunardi, C N ^a   Lima, R G ^a   Santos, C X ^a   Laurindo, F R M ^a   Silva, R S da ^a   Bendhack, L M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antioxidant; Nitric oxide donor; Renal hypertension; Superoxide anion

Indexed keywords

ASCORBIC ACID; CALCIUM ION; NITRIC OXIDE; NITRIC OXIDE DONOR; RUTHENIUM COMPLEX; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

RATTUS;

EID: 41149101535     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2007.12.002     Document Type: Article

References (36)

1. Arnold W.P., Mittal C.K., Katsuki S., and Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proceedings of the National Academy of Sciences of the United States of America 74 (1977) 3203-3207
2. 2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. Journal of Biological Chemistry 272 (1997) 5063-5068
3. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., and Cohen R.A. Nitric-oxide directly activates calcium-dependent potassium channels in vascular smooth-muscle. Nature 368 (1994) 850-853
4. Homer K.L., and Wanstall J.C. Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor. British Journal of Pharmacology 131 (2000) 673-682
5. + channels underlying the impaired acetylcholine-induced vasodilation in 2K-1C hypertensive rats. Journal of Pharmacology and Experimental Therapeutics 309 (2004) 1036-1042
6. + channel activation. Clinical and Experimental Pharmacology and Physiology 32 (2005) 478-481
7. Dhalla N.S., Temsah R.M., and Netticadan T. Role of oxidative stress in cardiovascular diseases. Journal of Hypertension 18 (2000) 655-673
8. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., and Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95 (1997) 588-593
9. Fukui T., Ishizaka N., Rajagopalan S., Lauren J.B., Capers Q., Taylor W.R., Harrison D.G., DeLeon H., Wilcox J.N., and Griendling K.K. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circulation Research 80 (1997) 45-51
10. Heitzer T., Wenzel U., Hink U., Krollner D., Skatchkov M., Stahl R.A.K., Macharzina R., Brasen J.H., Meinertz T., and Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney International 55 (1999) 252-260
11. Hamilton C.A., Brosnan M.J., McIntyre M., Graham D., and Dominiczak A.F. Superoxide excess in hypertension and aging--A common cause of endothelial dysfunction. Hypertension 37 (2001) 529-534
12. Newaz M.A., Nawal N.N.A., Rohaizan C.H., Muslim N., and Gapor A. Alpha-tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. American Journal of Hypertension 12 (1999) 839-844
13. Pezeshk A., and Dalhouse A.D. Vitamin E, membrane fluidity, and blood pressure in hypertensive and normotensive rats. Life Sciences 67 (2000) 1881-1889
14. Schnackenberg C.G., and Wilcox C.S. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F-2 alpha. Hypertension 33 (1999) 424-428
15. Vasdev S., Ford C.A., Parai S., Longerich L., and Gadag V. Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Molecular and Cellular Biochemistry 218 (2001) 97-103
16. Vasdev S., Gill V., Parai S., Longerich L., and Gadag V. Dietary vitamin E supplementation lowers blood pressure in spontaneously hypertensive rats. Molecular and Cellular Biochemistry 238 (2002) 111-117
17. Nakano D., Itoh C., Ishii F., Kawanishi H., Takaoka M., Kiso Y., Tsuruoka N., Tanaka T., and Matsumura Y. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats. Biological & Pharmaceutical Bulletin 26 (2003) 1701-1705
18. - (-) in DOCA-salt rats. Hypertension 43 (2004) 329-334
19. Noguchi T., Ikeda K., Sasaki Y., Yamamoto J., Seki J., Yamagata K., Nara Y., Hara H., Kakuta H., and Yamori Y. Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertension Research 24 (2001) 735-742
20. Chen X., Touyz R.M., Park J.B., and Schiffrin E.L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38 (2001) 606-611
21. +) complex and its vasodilator activity based on visible light irradiation. Inorganica Chimica Acta 359 (2006) 2543-2549
22. Bonaventura D., de Lima R.G., Vercesi J.A., da Silva R.S., and Bendhack L.M. Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex. Vascular Pharmacology 46 (2007) 215-222
23. Feelisch M., and Kelm M. Biotransformation of organic nitrates to nitric-oxide by vascular smooth-muscle and endothelial-cells. Biochemical and Biophysical Research Communications 180 (1991) 286-293
24. Bates J.N., Baker M.T., Guerra R., and Harrison D.G. Nitric-oxide generation from nitroprusside by vascular tissue--evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochemical Pharmacology 42 (1991) S157-S165
25. Goldblatt H., Lynch J., Hamzal R., and Summerville W. Studies on experimental hypertension. The production of persistent elevation of systolic blood pressure by means of renal ischemia. The Journal of Experimental Medicine 59 (1934) 347-379
26. Ulker S., McKeown P.P., and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41 (2003) 534-539
27. Rodrigues G.J., Restini C.B., Lunardi C.N., Moreira J.E., Lima R.G., da Silva R.S., and Bendhack L.M. Caveolae dysfunction contributes to impaired relaxation induced by nitric oxide donor in aorta from renal hypertensive rats. The Journal of Pharmacology and Experimental Therapeutics 323 (2007) 831-837
28. 2+reduction under visible light irradiation. FASEB Journal 20 (2006) A660-A661
29. Lunardi C.N., Cacciari A.L., Silva R.S., and Bendhack L.M. Cytosolic calcium concentration is reduced by photolysis of a nitrosyl ruthenium complex in vascular smooth muscle cells. Nitric Oxide--Biology and Chemistry 15 (2006) 252-258
30. Bonaventura D., Oliveira F.S., Lunardi C.N., Vercesi J.A., da Silva R.S., and Bendhack L.M. Characterization of the mechanisms of action and nitric oxide species involved in the relaxation induced by the ruthenium complex. Nitric Oxide--Biology and Chemistry 15 (2006) 387-394
31. Kojima H., Nakatsubo N., Kikuchi K., Urano Y., Higuchi T., Tanaka J., Kudo Y., and Nagano T. Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA. Neuroreport 9 (1998) 3345-3348
32. Fernandes D.C., Wosniak J., Pescatore L.A., Bertoline M.A., Liberman M., Laurindo F.R.M., and Santos C.X.C. Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems. American Journal of Physiology--Cell Physiology 292 (2007) C413-C422
33. Jung O., Schreiber J.G., Geiger H., Pedrazzini T., Busse R., and Brandes R.P. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109 (2004) 1795-1801
34. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin-Ii stimulates NADH and NADPH oxidase activity in cultured vascular smooth-muscle cells. Circulation Research 74 (1994) 1141-1148
35. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation--Contribution to alterations of vasomotor tone. Journal of Clinical Investigation 97 (1996) 1916-1923
36. Newaz M.A., Yousefipour Z., and Nawal N.N.A. Modulation of nitric oxide synthase activity in brain, liver, and blood vessels of spontaneously hypertensive rats by ascorbic acid: protection from free radical injury. Clinical and Experimental Hypertension 6 (2005) 497-508